Related Experiment Video

Updated: Jun 3, 2026

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Sex and gender differences in myocardial hypertrophy and heart failure

Vera Regitz-Zagrosek1, Ute Seeland

  • 1Institute of Gender in Medicine (GiM) and Center for Cardiovascular Research, Charité University Medicine, Berlin, Germany. vera.regitz-zagrosek@charite.de

Wiener Medizinische Wochenschrift (1946)
|April 5, 2011
PubMed

Insights

Cardiovascular disease affects men and women differently, with women experiencing better heart failure outcomes despite undertreatment. Understanding these gender differences is key to improving patient care and developing targeted clinical protocols.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Gender Medicine

Background:

  • Cardiovascular disease (CVD) is a leading global cause of death for both men and women.
  • While men often develop CVD earlier, women's risk significantly increases with age.
  • Heart failure (HF) is a major cause of cardiovascular mortality with a poor prognosis in both sexes.

Purpose of the Study:

  • To investigate the distinct risk factors, myocardial adaptations, and treatment outcomes in men and women with heart failure.
  • To explore the role of sex hormones, such as estrogens and testosterone, in mediating gender-specific cardiac remodeling.
  • To highlight disparities in HF management between genders and their impact on patient outcomes.

Main Methods:

  • Comparative analysis of cardiovascular disease prevalence and progression in men versus women.
  • Examination of myocardial remodeling patterns in male and female hearts.
  • Review of clinical data on HF management, including diagnosis, treatment, and invasive therapy utilization.
  • Inclusion of findings from clinical studies on gender differences in conditions like human aortic stenosis.

Main Results:

  • Female hearts exhibit a more favorable physiological myocardial remodeling compared to male hearts, potentially influenced by sex hormones.
  • Significant differences exist in HF risk factors and adaptations between genders.
  • Women with HF are often underdiagnosed, undertreated, and receive less invasive therapy compared to men.
  • Despite undertreatment, women frequently demonstrate better outcomes than men in HF management.

Conclusions:

  • Gender-specific research in cardiovascular disease, particularly heart failure, is crucial for advancing patient-oriented care.
  • Understanding sex differences in cardiac physiology and response to disease can inform the development of tailored clinical protocols.
  • Addressing gender disparities in diagnosis and treatment is essential for improving outcomes for all patients with cardiovascular conditions.

More Related Videos

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs14:35

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...